FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Cadence Pharmaceuticals Ofirmev Recall

OFIRMEV (acetaminophen) injection, 1000 mg/100 mL (10 mg/mL), 24-count Single Use 100 m…

Cadence Pharmaceuticals · San Diego, CA

Risk level
Class II
Reported by FDA
Aug 8, 2012
Recall ID
D-1432-2012
Check your lot numberHow we source this data

Summary

Cadence Pharmaceuticals recalled Ofirmev starting Jul 24, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1432-2012 on Aug 8, 2012. Reason: Presence of Particulate Matter: The firm initiated the recall due to visible presence of particulate matter. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: The firm initiated the recall due to visible presence of particulate matter.

Product description

OFIRMEV (acetaminophen) injection, 1000 mg/100 mL (10 mg/mL), 24-count Single Use 100 mL Vials per carton, Rx only, Manufactured for: Cadence Pharmaceuticals, Inc., San Diego, CA 92130, NDC 43825-102-01, UPC 3 43825 10201 7.

Lot numbers, UPCs & expiration codes

Lot #: V006015, V006023, V006031, V006056, V006064, V006080, V006106, V006114, V006130, V006148, V006155, Exp 07/12; V006171, V006189, V006197, V006205, V006213, V006221, V006254, V006262, V006270, V006296, V006304, V006312, V006320, V006338, V006346, V006353, V006361, V006379, V006387, V006395, Exp 08/12; V006403, V006429, V006437, V006445, V006460, V006494, V006510, V006528, V006536, V006544, Exp 09/12.

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1432-2012
Classification
Class II
Status
Terminated
Recall initiated
Jul 24, 2012
FDA report date
Aug 8, 2012
Quantity
1,098,912 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Cadence Pharmaceuticals

Original FDA data

Every field from FDA enforcement report D-1432-2012, exactly as published.

Show all FDA fields
City
San Diego
State
CA
Status
Terminated
Country
United States
Event ID
62643
Address
12481 High Bluff Dr Ste 200
Code information
Lot #: V006015, V006023, V006031, V006056, V006064, V006080, V006106, V006114, V006130, V006148, V006155, Exp 07/12; V006171, V006189, V006197, V006205, V006213, V006221, V006254, V006262, V006270, V006296, V006304, V006312, V006320, V006338, V006346, V006353, V006361, V006379, V006387, V006395, Exp 08/12; V006403, V006429, V006437, V006445, V006460, V006494, V006510, V006528, V006536, V006544, Exp 09/12.
Postal code
92130-3583
Report date
Aug 8, 2012
Product type
Drugs
Recall number
D-1432-2012
Classification
Class II
Recalling firm
Cadence Pharmaceuticals
Product quantity
1,098,912 vials
Termination date
Nov 4, 2013
Reason for recall
Presence of Particulate Matter: The firm initiated the recall due to visible presence of particulate matter.
Voluntary / mandated
Voluntary: Firm initiated
Product description
OFIRMEV (acetaminophen) injection, 1000 mg/100 mL (10 mg/mL), 24-count Single Use 100 mL Vials per carton, Rx only, Manufactured for: Cadence Pharmaceuticals, Inc., San Diego, CA 92130, NDC 43825-102-01, UPC 3 43825 10201 7.
Distribution pattern
Nationwide
Recall initiation date
Jul 24, 2012
Initial firm notification
Letter
Center classification date
Jul 31, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1432-2012, published Aug 8, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls